Clinical Trial: China Betaferon Adherence, Coping and Nurse Support Study
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: Prospective Study of Betaferon in Adherence, Coping and Nurse Support in Patients of Chinese Origin With Multiple Sclerosis
Brief Summary: Non-adherence reduces treatment benefit and can bias the assessment of treatment efficacy thereby involving safety risks for the patient and influencing health cost-effectiveness. This observational study will concentrate upon the role of MS nurses in influencing adherence. This study will examine the influence of initial and subsequent periodic nurse interviews which aim to improve adherence to Betaferon® treatment.
Detailed Summary:
Sponsor: Bayer
Current Primary Outcome: Adherence to Betaferon treatment: proportion of patients adhering to Betaferon treatment [ Time Frame: at 6, 12, 18 and 24 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Ways of Coping Questionnaire (WCQ) [ Time Frame: at 6, 12, 18 and 24 months ]
- Hospital Anxiety and Depression Scale (HAD) [ Time Frame: at 6, 12, 18 and 24 months ]
Original Secondary Outcome: Same as current
Information By: Bayer
Dates:
Date Received: September 19, 2011
Date Started: March 2012
Date Completion:
Last Updated: September 2, 2016
Last Verified: August 2016
